The Munich District Court in Germany has found that sleep masks produced by Fisher & Paykel Healthcare infringe a European patent owned by ResMed.
The US Federal Trade Commission yesterday said that Teva Pharmaceuticals has asked the commission to reopen and modify its decision and order regarding the 2012 merger of Actavis and Watson Pharmaceuticals.
Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants.
In a blow to Allergan and the Saint Regis Mohawk Tribe, the US Court of Appeals for the Federal Circuit yesterday refused to reconsider an earlier decision that rejected use of tribal sovereign immunity in inter partes reviews.
Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals.
AbbVie has announced that it has entered into a licensing deal with Germany-based pharmaceutical company Fresenius Kabi.
Amgen has invested £50 million ($66 million) in Oxford Nanopore Technologies, a UK company specialising in DNA/RNA sequencing technology.
The supplementary protection certificate manufacturing waiver “sends a worrying global signal that the EU is weakening its IP framework”, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The US Food and Drug Administration has announced that it has partnered with the US Department of Homeland Security as part of the FDA’s aim to strengthen cybersecurity in healthcare.
The US Food and Drug Administration has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed.